Celldex Therapeutics, Inc. Gains 82.4%
Thu, Jun 11, 2020 at 05:30 PM
Celldex Therapeutics, Inc. (CLDX:NASDAQ) soared at $8.76, a gain of 82.4%. On Wed 10 Jun 20, CLDX:NASDAQ touched a New 2-Week High of $4.8. The stock appeared on our News Catalysts scanner on Thu 11 Jun 20 at 02:44 PM in the 'INSIDER' category. From Wed 27 May 20, the stock recorded 50.00% Up Days and 72.73% Green Days
About Celldex Therapeutics, Inc. (CLDX:NASDAQ)
Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
Top 10 Gainers:
- Wah Fu Education Group Limited (WAFU:NASDAQ), 217.78%
- Wins Finance Holdings Inc. (WINS:NASDAQ), 146.18%
- Celldex Therapeutics, Inc. (CLDX:NASDAQ), 82.4%
- Therapix Biosciences Ltd. (TRPX:NASDAQ), 64.09%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 56.55%
- Lianluo Smart Limited (LLIT:NASDAQ), 44.64%
- Ambow Education Holding Ltd. (AMBO:NYSEMKT), 32.94%
- Huitao Technology Co., Ltd. (HHT:NASDAQ), 32.77%
- OptimumBank Holdings, Inc. (OPHC:NASDAQ), 31.75%
- IZEA Worldwide, Inc. (IZEA:NASDAQ), 29.95%